169 related articles for article (PubMed ID: 17367811)
1. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
Berger T; Reindl M
J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
[TBL] [Abstract][Full Text] [Related]
2. Antibodies as biological markers for pathophysiological processes in MS.
Reindl M; Khalil M; Berger T
J Neuroimmunol; 2006 Nov; 180(1-2):50-62. PubMed ID: 16934337
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
[TBL] [Abstract][Full Text] [Related]
4. Toward biomarkers in multiple sclerosis: new advances.
Lolli F; Rovero P; Chelli M; Papini AM
Expert Rev Neurother; 2006 May; 6(5):781-94. PubMed ID: 16734525
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of multiple sclerosis].
Simó M
Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
[TBL] [Abstract][Full Text] [Related]
6. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
7. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller DH; Montalban X; Polman C; Rocca MA; Thompson AJ; Yousry TA; Filippi M
Neurology; 2009 May; 72(19):1693-701. PubMed ID: 19433744
[TBL] [Abstract][Full Text] [Related]
8. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
Pachner AR; Brady J; Narayan K
J Neuroimmunol; 2007 Oct; 190(1-2):112-20. PubMed ID: 17919740
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
Frohman EM; Filippi M; Stuve O; Waxman SG; Corboy J; Phillips JT; Lucchinetti C; Wilken J; Karandikar N; Hemmer B; Monson N; De Keyser J; Hartung H; Steinman L; Oksenberg JR; Cree BA; Hauser S; Racke MK
Arch Neurol; 2005 Sep; 62(9):1345-56. PubMed ID: 16157741
[TBL] [Abstract][Full Text] [Related]
10. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Johnson AJ; Suidan GL; McDole J; Pirko I
Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of the cellular and molecular pathophysiology of multiple sclerosis.
Greenstein JI
Dev Neurobiol; 2007 Aug; 67(9):1248-65. PubMed ID: 17514718
[TBL] [Abstract][Full Text] [Related]
12. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
[TBL] [Abstract][Full Text] [Related]
13. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against light neurofilaments in multiple sclerosis patients.
Bartos A; Fialová L; Soukupová J; Kukal J; Malbohan I; Pitha J
Acta Neurol Scand; 2007 Aug; 116(2):100-7. PubMed ID: 17661795
[TBL] [Abstract][Full Text] [Related]
15. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
Somers K; Govarts C; Stinissen P; Somers V
Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
[TBL] [Abstract][Full Text] [Related]
16. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.
Antel J; Bar-Or A
J Neuroimmunol; 2006 Nov; 180(1-2):3-8. PubMed ID: 16934338
[TBL] [Abstract][Full Text] [Related]
17. [Molecular biomarkers for prediction of multiple sclerosis relapse].
Satoh J
Nihon Rinsho; 2008 Jun; 66(6):1103-11. PubMed ID: 18540355
[TBL] [Abstract][Full Text] [Related]
18. Development of biomarkers in multiple sclerosis.
Bielekova B; Martin R
Brain; 2004 Jul; 127(Pt 7):1463-78. PubMed ID: 15180926
[TBL] [Abstract][Full Text] [Related]
19. [MSRV retrovirus and gliotoxin protein: potential biological markers in multiple sclerosis?].
Perron H
Ann Biol Clin (Paris); 1998; 56(4):427-38. PubMed ID: 9754278
[TBL] [Abstract][Full Text] [Related]
20. The role of B cells and autoantibodies in multiple sclerosis.
Archelos JJ; Storch MK; Hartung HP
Ann Neurol; 2000 Jun; 47(6):694-706. PubMed ID: 10852535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
